Abbott Is Up 11% Today. The Real Story Is What Comes Next.
A Q2 beat and guidance raise just changed the investment case for one of MedTech's most overlooked compounders.
A Q2 beat and guidance raise just changed the investment case for one of MedTech's most overlooked compounders.
The Q3 guidance gap is the only number that matters right now.
AI's heat problem is a $15 billion backlog. Q2 earnings are two weeks away.
Inside the invisible material shortage throttling the world's most advanced chip factories.
A federal permit process now moving faster than any point in 40 years could unlock the most unconventional critical minerals…
AI's water bill is becoming its most underpriced infrastructure problem.